Lidings’ Senior Associate Boris Malakhov Speaks at Pharma & Biotech Patent Litigation Conference in Amsterdam

27 February 2018

Senior Associate of the Lidings’ Intellectual Property practice Boris Malakhov will take part in the Pharma & Biotech Patent Litigation Conference in Amsterdam on February 27-28th. The event is organized by the C5 Group, one of the world’s main conference providers.

The conference will gather together head of legal of major international pharmaceutical and biotechnological companies, senior legal advisers of the world’s leading law firms, patent specialists.

Boris Malakhov focused on dispute resolution and legal representation in all cases of infringement of intellectual property rights particularly involving pharmaceuticals and healthcare companies will make a special presentation dedicated to IP protection in pharma within the Eurasian Economic Union.

Lidings is a leading legal advisor in Russia, acting as an expert in the statutory regulation of the pharmaceutical industry. The firm’s clients are recognized leaders of the pharmaceutical market, such as AstraZeneca, Santen, Boehringer Ingelheim, Merck, Ipsen Pharmaceuticals, Astellas Pharma, Mallinckrodt Pharmaceuticals, MEDA Pharmaceuticals, Sanofi and many others. The firm frequently initiates and supports major international conferences devoted to issues most essential for the pharmaceutical industry in Russia and abroad. Lidings’ experts act as speakers and moderators in discussions on legal support of pharmaceutical companies doing business in the Russian Federation.

For more details about the conference and the list of participants please visit the official event’s website.